Solventum Corp | SOLV - Cash And Equivalent


Solventum Corp reported $561M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Align Technology USD 1.06B 35.07M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Cencora USD 2.18B 423.37M Mar/2026
Dexcom USD 1.12B 200.5M Mar/2026
Insulet USD 480.4M 235.7M Mar/2026
Solventum Corp USD 561M 317M Mar/2026
West Pharmaceutical Services USD 521.4M 269.9M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026